1Fava M, Kendler KS. Major depressive disorder [J]. Neuron, 2000,28(2) :335-341.
2Filip M, Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system [J]. Pharmacol Rep, 2009,61 (5) :761-777.
3Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineursj J], Neurology, 2005,65(4) :620.Q22.
4Clada P, Puig M, Amarg6s-Bosch M, et al. The therapeutic role of 5-HTIA and 5-HT2A receptors in depression [J]. J Psychiatr Neurosci, 2004 ,29( 4) :252-265.
5Dueottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor! antagonist antalarmin in the chronic mild stress model of depression in mice[J].Prog Neuropsychopharmacol BioI Psychiatry, 2003,27 ( 4) : 625 .Q31.
6Brea J, Castro-Palomino J, Yeste S, et al. Emerging opportunities and concern for drug discovery at serotonin 5-HT2B receptors [J]. Curr Top Med Chern, 2010,10(5) :493-503.
7Gomez-Merino 0, Bequet F, Berthelot M, et al. Evidence that the branched-chain amino acid L-valine prevents exercise-induced release of,5-HT in rat hippocampus [J]. Int J Sports Med, 2001,22 (5) :317-322.
8Nelson JC, Portera L, Leon AC. Are there differences in the symptoms that respond to a selective 5-hydroxytryptamine or norepinephrine reuptake inhibitor [J]. Bid Psychiatry, 2005, 57 ( 12 ) : 1535-1542.
9Borman RA, Tilford NS, Harmer OW, et al. 5-HT(2B)receptors play a key role in mediating the excitatory effects of 5 - HT in human colon in vitro [J]. Br J Pharmacol, 2002,135 (5) : 1144-1151.
10Drossman OA. Psychosocial aspects of the functional gastrointestinal disordersj J]. Gut, 1999,45(2) :25-30.
